5-Fluoro-3-indazolecarboxylic acid Chemical Properties

Melting point:

299 °C

Boiling point:

445.9±25.0 °C(Predicted)

Density 

1.610±0.06 g/cm3(Predicted)

storage temp. 

2-8°C

pka

2.89±0.30(Predicted)

Appearance

Light yellow to yellow Solid

InChI

InChI=1S/C8H5FN2O2/c9-4-1-2-6-5(3-4)7(8(12)13)11-10-6/h1-3H,(H,10,11)(H,12,13)

InChIKey

XFHIMKNXBUKQNS-UHFFFAOYSA-N

SMILES

N1C2=C(C=C(F)C=C2)C(C(O)=O)=N1

CAS DataBase Reference

1077-96-9(CAS DataBase Reference)

Safety Information

HS Code 

2917399590

5-Fluoro-3-indazolecarboxylic acid Usage And Synthesis

Uses

5-Fluoroinazole-3-carboxylic acid is a pharmaceutical intermediate.

Chemical Properties

yellow powder

Synthesis Reference(s)

Journal of Heterocyclic Chemistry, 1, p. 239, 1964 DOI: 10.1002/jhet.5570010505

Synthesis

The general procedure for the synthesis of 5-fluoroindazole-3-carboxylic acid from 5-fluoroindigo is as follows: first, sodium hydroxide (1.24 g, 0.031 mol, 1.03 eq.) was dissolved in water (19 mL) and heated to 50 °C, then 5-fluoroindigo (5 g, 0.03 mol, 1 eq.) was added. 5 minutes later, the resulting deep red solution was cooled to 0 °C, followed by the slow addition of a pre-cooled sodium nitrite (2.07 g, 0.03 mol, 1 eq.) solution in water (10 mL). Immediately thereafter, the cooled 95% sulfuric acid (3.12 mL, 0.06 mol, 1.95 eq.) water (48 mL) solution was added rapidly, controlling the rate of addition to ensure that the temperature did not exceed 4°C. A small amount of ether may be added at the appropriate time to minimize foaming during mixing. After the addition was complete, stirring was continued at less than 4°C for 1 hour. Subsequently, a 35% hydrochloric acid (24 mL) solution of pre-cooled stannous chloride (16.24 g, 0.072 mol, 2.4 eq.) was added and the mixture was stirred for 16 hours. After completion of the reaction, the brown solution was filtered and the resulting brown solid was washed with water to give a final light brown solid product (2.73 g, 51% yield). The NMR hydrogen spectral (MeOH-d4) data of the product were as follows: δH 7.25 (1H, td, J = 9.10 Hz and 2.14 Hz, ArH), 7.60 (1H, dd, J = 9.10 Hz and 4.28 Hz, ArH), 7.74 (1H, dd, J = 9.10 Hz and 2.10 Hz, ArH); LC-MS-EI showed the molecular ion peak m/z 183.1 (MH+, 100).

References

[1] Patent: WO2011/61469, 2011, A1. Location in patent: Page/Page column 34-35
[2] Patent: US2005/250808, 2005, A1. Location in patent: Page/Page column 39
[3] Patent: US2006/142247, 2006, A1. Location in patent: Page/Page column 39
[4] Patent: EP2565192, 2013, A1. Location in patent: Paragraph 0349
[5] Journal of Medicinal Chemistry, 2013, vol. 56, # 15, p. 6259 - 6272

5-Fluoro-3-indazolecarboxylic acid(1077-96-9)Related Product Information

• Oxygen-fluorine acid
• Indazole-3-carboxylic acid
• Triflumizole
• Flusilazole
• 1-[[(2S,3S)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole
• Levofloxacin carboxylic acid
• Ascoric Acid
• Fluorine
• 5-FLUORO-1-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID
• 5-FLUORO-1H-INDAZOLE
• 6-FLUORO-3-INDAZOLECARBOXYLIC ACID
• 3-CHLORO-4-FLUORO-6-INDAZOLECARBOXYLIC ACID
• 5,6-DIFLUORO-1H-INDAZOLE-3-CARBOXYLIC ACID
• ETHYL 5-FLUORO-1H-INDAZOLE-3-CARBOXYLATE
• ETHYL 5,6-DIFLUORO-1H-INDAZOLE-3-CARBOXYLATE
• METHYL 5,6-DIFLUORO-1H-INDAZOLE-3-CARBOXYLATE
• 1-Boc-5-fluoro-3-indazole-carboxylic Acid
• METHYL 5-FLUORO-1H-INDAZOLE-3-CARBOXYLATE